Gender Differences in Subjective Experience and Treatment of Bipolar Disorder

被引:21
|
作者
Kriegshauser, Kathryn [1 ]
Sajatovic, Martha [1 ]
Jenkins, Janis H. [2 ]
Cassidy, Kristin A. [1 ]
Muzina, David [3 ]
Fattal, Omar [4 ]
Smith, Douglas [5 ]
Singer, Beth [5 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
[2] Univ Calif San Diego, Dept Anthropol, San Diego, CA 92103 USA
[3] Cleveland Clin, Dept Psychiat & Psychol, Cleveland, OH 44106 USA
[4] Lutheran Hosp, Dept Psychiat, Cleveland, OH USA
[5] Northcoast Behav Healthcare, Northfield, OH USA
关键词
Bipolar disorder; treatment adherence; gender differences; DEPRESSION; ADHERENCE;
D O I
10.1097/NMD.0b013e3181da8ef7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Treatment nonadherence is a leading cause of poor outcomes among populations with bipolar disorder (BD) and is related to subjective experience of illness and treatment. This study examined gender differences in the experience of illness and treatment for those with BD, specifically in regards to treatment adherence. This cross-sectional analysis pooled data from 3 BD studies. A semistructured qualitative instrument, the Subjective Experience of Medication Interview, elicited information on subjective differences in treatment adherence between men and women. Men and women experience comparable levels of stigma and they comparably value lessened irritability and/or impulsivity because of medications. However, men and women differed in fear of weight gain because of medications, value of social support, and self-medication behaviors. Selected differences in subjective illness experience between men and women might be used to inform gender-sensitive approaches to enhance treatment adherence among populations with BD.
引用
收藏
页码:370 / 372
页数:3
相关论文
共 50 条
  • [1] Gender differences in health care and treatment of bipolar disorder
    Landen, M.
    Elert, C.
    Ludvigsson, U.
    [J]. BIPOLAR DISORDERS, 2007, 9 : 62 - 63
  • [2] Gender differences in bipolar disorder
    Arnold, LM
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2003, 26 (03) : 595 - +
  • [3] Gender differences in bipolar disorder: the systematic treatment enhancement program for bipolar disorders
    Dennehy, E.
    Baldassano, C. F.
    Thase, M. E.
    Sachs, G. S.
    [J]. BIPOLAR DISORDERS, 2009, 11 : 33 - 33
  • [4] Gender differences in phenomenology, service utilization and treatment for bipolar disorder
    Schaffer, A
    Cairney, J
    Cheung, A
    Veldhuizen, S
    Levitt, A
    [J]. BIPOLAR DISORDERS, 2005, 7 : 95 - 95
  • [5] Bipolar disorder and adherence: implications of manic subjective experience on treatment disruption
    Bulteau, Samuel
    Grall-Bronnec, Marie
    Bars, Pierre-Yves
    Laforgue, Edouard-Jules
    Etcheverrigaray, Francois
    Loirat, Jean-Christophe
    Victorri-Vigneau, Caroline
    Vanelle, Jean-Marie
    Sauvaget, Anne
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1355 - 1361
  • [6] Gender differences in dual bipolar disorder
    Mateu-Codina, G.
    Sauras-Quetcuti, R.
    Farre-Martinez, A.
    Galindo-Guarin, L.
    Marti-Bonany, J.
    Hurtado-Ruiz, M. G.
    Campillo-Saenz, M.
    Sanchez-Gonzalez, R.
    Castillo-Buenaventura, C.
    Torrens-Melich, M.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S477 - S478
  • [7] Gender differences in bipolar–II disorder
    F. Benazzi
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2006, 256 : 67 - 71
  • [8] Gender differences in the phenomenology of bipolar disorder
    Kessing, LV
    [J]. BIPOLAR DISORDERS, 2004, 6 (05) : 421 - 425
  • [9] Gender differences in the treatment of patients with bipolar disorder: A study of 7354 patients
    Karanti, Alina
    Bobeck, Christian
    Osterman, Maja
    Kardell, Mathias
    Tidemalm, Dag
    Runeson, Bo
    Lichtenstein, Paul
    Landen, Mikael
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 174 : 303 - 309
  • [10] Lifetime comorbidity in bipolar disorder: bipolar subtype and gender differences
    Grabski, B.
    Dudek, D.
    Datka, W.
    Maczka, G.
    Zieba, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S546 - S547